• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100110 利格列汀片 linagliptin Tablet Chemical Drugs Supplementary Application 2021-02-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-02-02 view
JXHL2100018 BI685509片 Avenciguat Tablet Chemical Drugs(1) Import Drug Application 2021-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-18 view
JXHL2100019 BI685509片 Avenciguat Tablet Chemical Drugs(1) Import Drug Application 2021-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-18 view
JYHB2100070 利格列汀二甲双胍片(Ⅱ) linagliptin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2021-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2021-02-01 view
JXHL2100020 BI685509片 Avenciguat Tablet Chemical Drugs(1) Import Drug Application 2021-01-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-18 view
JXHL2100015 BI 425809 片 iclepertin Tablet Chemical Drugs(1) Import Drug Application 2021-01-16 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-15 view
JXHL2000357 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-04 view
JXHL2000356 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-04 view
JXHL2000360 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-04 view
JXHL2000359 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-04 view
JXHL2000358 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2021-01-04 view
JYHB2002711 利格列汀二甲双胍片(Ⅱ) linagliptin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-29 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-29 view
JYHB2002710 利格列汀二甲双胍片(Ⅱ) linagliptin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-12-29 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-29 view
JXHL2000336 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JYHB2002638 异丙托溴铵吸入气雾剂 ipratropium bromide Aerosol Chemical Drugs Supplementary Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JXHL2000335 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JXSB2000052 BI655130注射液 spesolimab Injection Biological Products Supplementary Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JXHL2000339 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JXHL2000338 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view
JXHL2000337 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd In Review 2020-12-19 view